Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
DNL-343 by Denali Therapeutics for Amyotrophic Lateral Sclerosis: Likelihood of Approval
DNL-343 is under clinical development by Denali Therapeutics and currently in Phase III for Amyotrophic Lateral Sclerosis. According to GlobalData,...
Data Insights
BL-001 by Bloom Science for Amyotrophic Lateral Sclerosis: Likelihood of Approval
BL-001 is under clinical development by Bloom Science and currently in Phase I for Amyotrophic Lateral Sclerosis. According to GlobalData,...